Healthcare ❯ Pharmaceuticals

Drug Production

Generic Medications Import Regulations Supply Chain Market Dynamics Doliprane GLP-1 Drugs Weight Management Quality Control Active Pharmaceutical Ingredients Cancer Treatments Regulatory Affairs Supply Chain Issues HLB Pharma Generics

Novo Nordisk Invests €432 Million to Expand Athlone Plant for Oral GLP-1 Tablets

The upgrade positions the site to supply markets outside the U.S. ahead of a possible EMA decision on the Wegovy pill.